DHAC SEC filings, in plain English
Everything DIGITAL HEALTH ACQUISITION CORP. has filed with the SEC that we hold — 40 filings, newest first, 9 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: VSee Health, Inc. filed an 8-K reporting the final results of its August 25, 2026 Annual Meeting of Stockholders. The filing confirms that stockholders elected Kevin Lowdermilk and Colin O’Sullivan to the Board (holding office until the 2029 annual meeting), ratified WWC, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved a proposal granting discretionary authority to the Board to effect one or more reverse stock splits at a ratio within the range of 1-for-20 up to 1-for-80, provided any such split is completed no later than the second anniversary of the Record Date (July 6, 2026). Why it matters: The approval of the reverse stock split authority represents a significant structural change to the company's capitalization, potentially impacting liquidity and share price stability, while the election of new directors and ratification of auditors confirms the continuity of governance and financial oversight for the current fiscal year.
What changed: Q2 2026 10-Q of VSee Health, Inc. (VSEE, quoted on OTC), filed under Digital Health Acquisition Corp's CIK. Cash fell to $454,151 from $5,051,445 at December 31, 2025; accounts receivable were $2,231,040 net of a credit-loss allowance that rose to $1,642,234 from $835,007. Total current assets were $3,266,387 versus $8,365,407 and total assets $16,734,408 versus $22,413,019, including goodwill of $4,916,694 and intangibles of $7,680,004. Why it matters: Cash is down about 91% over the half-year while total liabilities fell by roughly $7.8 million, largely through the disappearance of discontinued-operations balances. Both the common stock and the $11.50 warrants are quoted on OTC rather than an exchange.
going-concern doubt, sponsor loans outstandingnothing moved · 2 with no prior record of ours
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $505K · unchanged
The clause …“Officer and Chairman of the Board of Directors in connection therewith. Going Concern Management has determined that principal conditions including the Company’s liquidity condition and historical operating losses raise”…
The clause …“as of June 30, 2026, and December 31, 2025. . (3) On June 24, 2024, DHAC owed the Sponsor and certain Sponsor affiliates $ 504,659 in advance to cover working capital needs, which were non-interest bearing due on demand. On June”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: 8-K of VSee Health, Inc. Item 3.01 (notice of delisting or failure to satisfy a continued listing standard): on July 30, 2026 Nasdaq Staff notified the Company that as of July 29, 2026 its securities had a closing bid price of $0.10 or less for ten consecutive trading days, triggering Listing Rule 5810(c)(3)(A)(iii), and that Staff has determined to delist the securities from the Nasdaq Capital Market. Trading in the common stock and warrants will be suspended at the opening of business on August 6, 2026 and a Form 25-NSE will be filed. Why it matters: The report states a Panel appeal is available under the Rule 5800 Series but must be requested with a non-refundable $20,000 fee by 4:00 p.m. Eastern on August 6, 2026, and that under Rule 5815(a)(1)(B)(ii)(e) a timely hearing request will NOT stay the trading suspension. The Company says it is considering all available options and gives no assurance any appeal succeeds. Delisting, not a deficiency notice.
What changed: 8-K of VSee Health, Inc. Item 1.01 (entry into a material definitive agreement): on June 30, 2026 the Company entered a securities purchase agreement with an institutional investor, Labrys, and issued an unsecured convertible promissory note of $336,000 aggregate principal including a $36,000 original issue discount, carrying a one-time 12% interest charge guaranteed and earned in full at issuance and due June 30, 2027. Labrys may require up to 50% of any cash proceeds the Company or its subsidiaries receive from almost any source to be applied to repayment. Why it matters: The conversion price is 75% of the lowest closing bid price over the ten trading days before a conversion notice, with a 4.99% beneficial-ownership cap, and conversion opens on the earlier of a missed amortization payment, 180 days after issuance, or registration of the conversion shares. A discount to the lowest recent bid means the share count issued rises as the price falls. The same registrant reported a Nasdaq delisting determination on July 30, 2026.
What changed: 8-K of VSee Health, Inc. Item 1.01 (entry into a material definitive agreement): on July 21, 2026 the Company entered a Settlement Agreement and Mutual Release with ADI Funding LLC and M2B Funding Corp., resolving disputes over a June 8, 2026 Secured Promissory Note of $271,739.13 original principal. ADI had alleged an Event of Default on June 11, 2026 for failure to file an S-1 registering equity line of credit resale shares, failure to file an 8-K on the ELOC and failure to instruct the transfer agent to issue M2B commitment shares by that date. Why it matters: The Company must repay the existing note on the earlier of ninety days after execution or immediately on receiving Financing Transaction proceeds, applying 50% of gross proceeds from any financing and 100% of ELOC proceeds until repaid; pay ADI $50,000 within three business days with a $500 per day late charge and no cure period; and issue a further $50,000 six-month note, interest-free until maturity but accruing 18% retroactively if unpaid, convertible at 75% of the lowest VWAP over 20 trading days.
What changed: VSee Health, Inc., the successor to Digital Health Acquisition Corp, called its annual meeting for 25 August 2026 at 10:00 a.m. Eastern, record date 6 July 2026. Proposal No. 3 asks stockholders to grant the board discretionary authority to amend the certificate of incorporation to effect one or more consolidations of the outstanding $0.0001 par common stock — a reverse stock split, at the board's discretion, in one or more steps. Common trades on the Nasdaq Capital Market as VSEE and the redeemable public warrants as VSEEW. Why it matters: A board asking for open-ended, repeatable reverse-split authority is asking for the tool used to hold a Nasdaq listing when the bid price has fallen under $1.00. That is the standard post-de-SPAC distress sequence, and it belongs in Digital Health Acquisition Corp's outcome record. The warrants remain listed, so warrant holders face the same split arithmetic on an instrument that is already far out of the money.
What changed: VSee Health, Inc., the Digital Health Acquisition Corp. successor, reported that on July 6, 2026 its board ratified August 25, 2026 as the date of the 2026 annual meeting and July 6, 2026 as the record date. Stockholder proposals for inclusion under Rule 14a-8, and notices for purposes of discretionary voting authority under Rule 14a-4(c), had to reach the principal executive offices by the close of business on July 17, 2026, which the company determined to be a reasonable time before printing and distributing proxy materials. Full meeting details would follow in the proxy statement. Why it matters: The eleven-day window between the board's ratification and the July 17, 2026 proposal deadline is the point of substance: setting the meeting date and the submission cut-off almost simultaneously leaves stockholders very little time to advance a proposal or a nomination. That is permissible under Rule 14a-8 where the timetable is reasonable, but it effectively forecloses outside proposals at a meeting whose agenda includes a discretionary reverse stock split authorisation.
What changed: VSee Health, Inc., the Digital Health Acquisition Corp. successor, filed the preliminary proxy for its annual meeting on August 25, 2026 at 10:00 a.m. ET, with a July 6, 2026 record date. Proposal No. 3 asks stockholders to grant the board discretionary authority to amend the certificate of incorporation to effect one or more reverse stock splits combining and reclassifying the outstanding $0.0001 par value common stock. Common stock trades on the Nasdaq Capital Market as VSEE and the public warrants as VSEEW. Holders of common stock and Series A Preferred at the record date may vote. Why it matters: The preliminary version of the proxy that later became definitive on July 20, 2026 — the terms carried through unchanged, so the operative document is the later filing. The substance is the open-ended split authority: the board would be able to run one or more consolidations at ratios and times it chooses without returning to stockholders, which is the standard defence against a Nasdaq minimum bid price problem and which resets the VSEEW warrant economics each time it is used.
What changed: VSee Health, Inc., the Digital Health Acquisition Corp. successor, filed a promissory note issued to Vanquish Funding Group Inc. dated June 18, 2026 with a principal amount of $295,550.00 against a purchase price of $257,000.00, an original issue discount of $38,550.00, maturing April 15, 2027. The note may not be prepaid except as expressly provided, and any principal or interest not paid when due bears default interest at 22% a year. Payments not converted into common stock are due in cash, and the note is issued under a securities purchase agreement of the same date. Why it matters: An original issue discount of $38,550 on $257,000 of cash is a 15% cost before any interest, and a 22% default rate on top of that is the pricing of a lender that expects to be repaid in stock rather than cash. A company borrowing $257,000 on those terms has no cheaper source, which explains why the same issuer is asking stockholders for open-ended reverse split authority. For former DHAC holders the conversion feature makes this note a dilution instrument, not a loan.
- What changed vs 2025-11-14sponsor loan $591K → $505K
sponsor loans outstanding, combination deadline, going-concern doubt1 moved · 2 with no prior record of ours
- Sponsor loans outstanding
- $591K$505K
- Combination deadline
- 2024-12-31not matched in this filing
- Going-concern doubt
- stated · unchanged
SpacBrain reads this as $85,848 of sponsor debt has come off.
The clause “2026, and December 31, 2025. . 33 Table of Contents (3) On June 24, 2024, DHAC owed the Sponsor and certain Sponsor affiliates $ 504,659 in advance to cover working capital needs, which were non-interest bearing due on demand. On June”…
The clause …“Combinations, with the excess purchase consideration recorded as goodwill. Going Concern Management has determined that principal conditions including the Company’s liquidity condition and historical operating losses raise”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
combination deadline, going-concern doubt, sponsor loans outstandingnothing moved · 3 with no prior record of ours
- Combination deadline
- 2024-12-31 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $505K · unchanged
The clause …“the maturity date of the ELOC Commitment Fee Note from September 23, 2024, to December 31, 2024. The Company accounted for the extension of the maturity date as an extinguishment. The Company recorded a gain on extinguishment of $ 5,000”…
The clause …“could decline. There is uncertainty regarding our ability to continue as a going concern. Our independent registered public accounting firm included an explanatory paragraph in its report on our consolidated financial statements as”…
The clause “00,000 related to the future common stock issuances. (6) On June 24, 2024, DHAC owed the Sponsor and certain Sponsor affiliates $ 504,659 in advance to cover working capital needs, which were non-interest bearing due on demand. On June”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.